NABI (Nabi Biopharmaceu)
All Pro Portfolios with NABI
- Total Pro Portfolios with NABI:
- Third Point LLC
- show more
All Do-It-Yourself Portfolios with NABI
- Total Do-It-Yourself Portfolios with NABI:
- AShah Biotech Portfolio
- m.z.ghieth Portfolio 1
- Barrons Activist Situations - 10-16
- PRossmango - Speculative Low Stock Price Account
- joemack30 Portfolio 1
- Wertheimer Capital
- Steven Nadler Portfolio 1
- FAPortfolio
- frankwb Portfolio 1
- mileslb Fidelity IRA
- armygrunt Portfolio 1
- Biotech Short Squeezes
- Cheap spec
- BottomFeeder787
- heydude
- D's Stock Picks
- docnijjar Portfolio 1
- clarsen Portfolio 1
- Miss Equity
- PANTERA GROUP 145
- Barron's Insider Purchases 1-24-2009
- show more
- 42
- Peter Chang Portfolio 1
- Lloyd's Portfolio 1
- Barrons Activist Stocks - 10-23-06
- Hyrum Portfolio 1
- Bernard Pogensky Portfolio 1
- Howard D. Portfolio 1
- mikecusfm Portfolio 1
- qualitysiding Portfolio 1
- dc portfolio1
- Budddy
- jakjoszac Portfolio 1
- crenny53 Portfolio 1
- HACIENDA
- purpleshasta Portfolio 1
- edwardk Portfolio 1
- River 1
- SUPRATRADE 3007071748
- Top Short Squeezes
- 10 Stocks With Low Floats And High Short Interest
- bradgossard Portfolio 1
- Charts of the Week - 1-27-2009
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- Nabi Smoking (NABI, GSK)
- show more
- 16/11/09
Why I Love This Stock |
|
By:sarah z |
Date:08 21 07 |
Short Interest Ratio: 21 |
|
Not yet rated
Rate now:
|
|
By:Slaur8 |
Date:07 12 07 |
1) Thot it would go up |
|
Not yet rated
Rate now:
|
|
By:fredparks |
Date:02 10 07 |
oversold |
|
Not yet rated
Rate now:
|
|
By:xGuest |
Date:11 30 -1 |
Third Point thinks NABI should no longer be a public company. |
|
Not yet rated
Rate now:
|
|
By:Pam |
Date:11 30 -1 |
Knott Partners is joining Third Point in requesting that the CEO leave. |
|
Not yet rated
Rate now:
|
|
By:Guest |
Date:11 30 -1 |
Nabi BioPhama. Third Point. Dan Loeb wants to remove the chairmnan and CEO. Third Point owns 9.5% |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
